CDT Announces Investment in Pep'd, Expanding into the Fast-Growing US Peptide Market
CDT Equity Inc. (Nasdaq: CDT) announced a SAFE note investment in Pep'd Inc., a US-based peptide telehealth company, to gain exposure to the growing peptide therapeutics market projected to reach $294.6 billion by 2033. The investment leverages AI-enabled approaches for peptide development and combines telehealth with research capabilities. Pep'd is controlled by CDT's CEO Dr. Andrew Regan.